About this trial
This study looks at whether transcranial Direct Current Stimulation (tDCS) can be effectively implemented in inpatient and outpatient rehabilitation settings during routine speech therapy for people who recently had a stroke and now have aphasia (difficulty speaking or understanding language)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ischemic or hemorrhagic stroke
aphasia
Disqualifiers
not a patient at either inpatient and outpatient settings of Casa Colina Hospital and Centers for Healthcare
Trial population
adult stroke patients with aphasia of inpatient and outpatient settings of Casa Colina Hospital and Centers for Healthcare
Trial design
Other
Prospective
Treatments tested in this trial
transcranial direct current stimulation (tDCS)
Device20 minute anodal tDCS (1mA) to the left inferior frontal (Broca) area, concurrent with speech and language therapy by a trained speech language pathologist (SLP) over their stay (during at least 5 sessions)
Treatment groups
Trial outcomes
Primary outcomes
Nasa Taskload Index (NTI)
The NASA Task Load Index (NTI) is a widely used tool for measuring how demanding a task feels to a person. It captures subjective workload, meaning it asks individuals to rate how challenging a task was for them. It was developed by NASA researchers in the 1980s to better understand how mental and physical demands affect performance
Theoretical Domain Framework (TDF) questionnaire
The Theoretical Domains Framework (TDF) is a structured approach used to understand why people do or do not change behavior in healthcare and other settings. It brings together key concepts from multiple behavior-change theories into a single framework to help identify barriers and facilitators to implementing new practices.
Secondary outcomes
Western Aphasia Battery Revised (WABr)
The Western Aphasia Battery-Revised (WAB-R) is a standardized assessment used to identify the presence, type, and severity of aphasia in adults with acquired brain injury, most commonly stroke. It evaluates multiple language skills, including speech production, comprehension, repetition, and naming, as well as reading and writing.
Other outcomes
Adverse Event Questionnaire (AEQ)
The Adverse Event Questionnaire (AEQ) is a safety monitoring tool used to systematically record any unwanted or unexpected symptoms that occur during or after an intervention. It typically asks participants or clinicians to report the type, severity, timing, and duration of potential side effects. In this study, the AEQ is used to report known, low-risk side effects of tDCS, such as scalp tingling, skin irritation, headache, or fatigue.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: